Table 3.
Antihypertensive treatment | Percentage of patients, % | Control rate, % |
---|---|---|
Monotherapy (n = 14 305) | 73.3 | 60.6 |
Angiotensin‐converting enzyme inhibitors | 4.9 | 50.0 |
Angiotensin receptor blockers | 17.1 | 68.2 |
Long‐acting calcium channel blockers | 37.2 | 60.9 |
Short‐acting calcium channel blockers | 7.2 | 51.1 |
Diuretics | 2.7 | 49.4 |
β‐blockers | 2.7 | 68.2 |
Other a | 1.4 | 51.6 |
Combination therapy (n = 5218) | 26.7 | 63.1 |
Fixed‐dose combination | 8.5 | 58.1 |
An angiotensin‐converting enzyme inhibitor or an angiotensin receptor blocker plus hydrochlorothiazide | 4.5 | 71.6 |
Hydrochlorothiazide plus reserpine or clonidine | 4.0 | 42.9 |
Free combination | 18.2 | 65.4 |
Values are percentage of patients.
Including α‐blockers, reserpine, clonidine, isosorbide mononitrate, and Chinese herbs.